A Study in Healthy People to Test Whether BI 3000202 Affects How 2 Other Medicines (Rosuvastatin and Digoxin) Are Taken up in the Body

Rho Kinase in Patients With Atherosclerosis

NCT00115830 ·Status: COMPLETED ·Phase: PHASE3

48-wk Open Label Phase IIIb to Evaluate Efficacy and Safety

NCT00654602 ·Status: COMPLETED ·Phase: PHASE3

Rosuvastatin Impact on Ventricular Remodelling Lipids and Cytokines

NCT00240292 ·Status: COMPLETED ·Phase: PHASE3

Assessment of the Effect of Food on ABT-143 Bioavailability

NCT00719693 ·Status: COMPLETED ·Phase: PHASE1

Evaluating Bioequivalence of a Fixed Dose Combination Versus Tablets of Bempedoic Acid / Ezetimibe and Rosuvastatin

NCT07201545 ·Status: COMPLETED ·Phase: PHASE1

Effects in The ApoB/ApoA-I Ratio Using Rosuvastatin and Atorvastatin in Patients With Acute Coronary Syndrome

NCT00296387 ·Status: COMPLETED ·Phase: PHASE3

A Drug-Drug Interaction Study To Estimate The Effect Of Tafamidis On Rosuvastatin Pharmacokinetics

NCT04253353 ·Status: COMPLETED ·Phase: PHASE1

Assessment of the Lipid Lowering Effect of Rosuvastatin Compared to Atorvastatin in Subjects With Coronary Heart Disease

NCT00235950 ·Status: COMPLETED ·Phase: PHASE4

A Study to Investigate the Effect of Oral Ticagrelor on the Pharmacokinetics of Oral Rosuvastatin When Given in Healthy Participants

NCT06554821 ·Status: COMPLETED ·Phase: PHASE1

Study to Learn the Effect of Drug BAY1817080 on the Way the Body Absorbs, Distributes and Excretes Another Drug Rosuvastatin in Healthy Adult Participants

NCT04252300 ·Status: COMPLETED ·Phase: PHASE1

A Study of RO4917838 With Rosuvastatin in Healthy Volunteers

NCT01183585 ·Status: COMPLETED ·Phase: PHASE1

Study of PF-04965842 Effect on Rosuvastatin Pharmacokinetics in Healthy Participants

NCT03806101 ·Status: COMPLETED ·Phase: PHASE1

to Investigate the Pharmacokinetic Interactions and Safety Between Rosuvastatin and Ezetimibe in Healthy Male Volunteers

NCT02289430 ·Status: COMPLETED ·Phase: PHASE1

Evaluation of Effects of Rosuvastatin 40mg on Myocardial Ischemia in Subjects With Coronary Artery Disease

NCT00657527 ·Status: COMPLETED ·Phase: PHASE3

Interaction Between ABT-335, Rosuvastatin and Warfarin

NCT00487136 ·Status: COMPLETED ·Phase: PHASE1

Comparison of the Bioavailability of Fenofibric Acid and Rosuvastatin From ABT-143 Relative to That From the Coadministration of ABT-335 (Fenofibric Acid) and Rosuvastatin Calcium

NCT00808678 ·Status: COMPLETED ·Phase: PHASE1

A Study of PF-06651600 Effect on Rosuvastatin Pharmacokinetics in Healthy Participants

NCT04092595 ·Status: COMPLETED ·Phase: PHASE1

Crestor Versus Placebo in Subjects With Heart Failure

NCT00206310 ·Status: COMPLETED ·Phase: PHASE3

Safety Study to Evaluate the Effects of Mild and Moderate Renal Impairment on the Pharmacokinetics of ABT-335 and Rosuvastatin When Administered Concomitantly

NCT00585143 ·Status: COMPLETED ·Phase: PHASE1

Effects of Rosuvastatin on the, in Vivo, Kinetic of apoB and apoA1, Using Stable Isotopes, in Type 2 Diabetic Patients

NCT00658463 ·Status: COMPLETED ·Phase: PHASE4

Comparison of the Bioavailability of Fenofibric Acid and Rosuvastatin From 5/45 mg Strength of ABT-143 Relative to That From the Coadministration of ABT-335 (Fenofibric Acid) 45 mg and Rosuvastatin Calcium 5 mg

NCT00826358 ·Status: COMPLETED ·Phase: PHASE1

Drug Interaction Study With Rosuvastatin

NCT02101125 ·Status: COMPLETED ·Phase: PHASE1

Pharmacokinetic Drug Interaction Between Rosuvastatin and Valsartan

NCT01609907 ·Status: COMPLETED ·Phase: PHASE1

A Study To Evaluate the Effect of Rosuvastatin On Intravascular Ultrasound-Derived Coronary Atheroma Burden (ASTEROID)

NCT00240318 ·Status: COMPLETED ·Phase: PHASE3

A Study to Learn How Much Rosuvastatin Gets Into the Blood When Taken With or Without Elinzanetant and to Learn About the Safety of Elinzanetant in Healthy Participants

NCT04889287 ·Status: COMPLETED ·Phase: PHASE1